A biotech company specializing in oncology therapies has seen its stock price jump 250% over the past year. This surge follows a recent disclosure of a new $10 million position by an unnamed investor.
Biotech Firm Shares Surge 250% After Investor Discloses $10 Million Stake
BiotechnologyStocksInvestingOncologyHealthcare



